News & Event
- Home
- News
- News & Event
Chungbuk-do and Cheongju-si signed an MOU with BINEX for investment in Osong plant
On February 14th, Chungbuk-do and Cheongju-si signed an investment agreement with BINEX for the new construction and expansion of a biopharmaceutical manufacturing plant.
BINEX plans to expand its production facilities at the Osong plant to enhance its biopharmaceutical manufacturing and development capabilities, as well as increase its workforce.
BINEX, founded in 1985, is a leading domestic biopharmaceutical manufacturer and is expanding its presence in the global market based on its Contract Development and Manufacturing Organization (CDMO) business.
The Osong plant, one of its core production facilities, is scheduled for a U.S. FDA inspection in 2026.
Cheongju Deputy Mayor stated, "BINEX's investment decision is of great significance for the development of Cheongju's biopharmaceutical industry and the revitalization of the local economy," adding, "We will continue to provide active support to ensure the company’s stable growth."
kw@yna.co.kr
Source Text
** This article was translated from Korean.
Date
2025.02.17
Views
90
According to Yonhap News,
On February 14th, Chungbuk-do and Cheongju-si signed an investment agreement with BINEX for the new construction and expansion of a biopharmaceutical manufacturing plant.
BINEX plans to expand its production facilities at the Osong plant to enhance its biopharmaceutical manufacturing and development capabilities, as well as increase its workforce.
BINEX, founded in 1985, is a leading domestic biopharmaceutical manufacturer and is expanding its presence in the global market based on its Contract Development and Manufacturing Organization (CDMO) business.
The Osong plant, one of its core production facilities, is scheduled for a U.S. FDA inspection in 2026.
Cheongju Deputy Mayor stated, "BINEX's investment decision is of great significance for the development of Cheongju's biopharmaceutical industry and the revitalization of the local economy," adding, "We will continue to provide active support to ensure the company’s stable growth."
kw@yna.co.kr
Source Text
Copyrights Yonhap News. All Rights Reserved.
Reprint or redistribution without permission is prohibited.
Source: Yonhap News (February 14, 2025)
** This article was translated from Korean.